Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC5A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PDLIM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TDRD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSAMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF610 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZCCHC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESRRG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR52K3P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVIL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFT27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on